News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
291 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17924)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (21)
2 (28)
3 (291)
4 (299)
5 (210)
6 (198)
7 (88)
8 (20)
9 (26)
10 (204)
11 (264)
12 (223)
13 (206)
14 (127)
15 (5)
16 (12)
17 (183)
18 (268)
19 (197)
20 (202)
21 (95)
22 (5)
23 (6)
24 (193)
25 (218)
26 (195)
27 (217)
28 (97)
29 (2)
30 (3)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
Xolair (Omalizumab) Significantly Reduced Nasal Polyps and Congestion Symptoms in Adults with Chronic Rhinosinusitis with Nasal Polyps in Two Phase III Studies
Genentech, a member of the Roche Group, announced positive topline data from two Phase III multicenter studies evaluating Xolair® for the treatment of adults with chronic rhinosinusitis with nasal polyps who have not adequately responded to intranasal corticosteroids.
June 3, 2019
·
9 min read
Targovax Announces Publication of in vivo Abscopal Effect of ONCOS-102 and Keytruda Combination
Targovax ASA announces that a study showing abscopal effect of ONCOS-102 and Keytruda combination treatment in a humanized mouse melanoma model has been accepted for publication in the Journal of Medical Virology.
June 3, 2019
·
2 min read
Targovax Announces Publication of in vivo Abscopal Effect of ONCOS-102 and Keytruda Combination - June 3, 2019
Targovax ASA announces that a study showing abscopal effect of ONCOS-102 and Keytruda combination treatment in a humanized mouse melanoma model has been accepted for publication in the Journal of Medical Virology.
June 3, 2019
·
2 min read
Drug Development
New Data From the Phase I Study of Birinapant in Combination With Keytruda® Presented at ASCO
Medivir AB informs that new data from the phase I study of birinapant in combination with pembrolizumab was presented at an oral session on June 2nd at the American Society of Clinical Oncology annual meeting in Chicago, USA.
June 3, 2019
·
3 min read
Drug Development
New Data from GEOMETRY mono-1 Study Show Clinically Meaningful Results in Patients with Non-Small Cell Lung Cancer with MET exon-14 Skipping Mutation Treated with Capmatinib
Incyte announced primary efficacy results from the Novartis-sponsored GEOMETRY mono-1 Phase 2 clinical trial of capmatinib, an investigational, selective MET inhibitor.
June 3, 2019
·
7 min read
Final Progression-Free Survival Data and the Second Interim Analysis of Overall Survival from the J-ALEX Study for Alecensa Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
Chugai Pharmaceutical Co., Ltd. announced that the final progression-free survival data and the second interim analysis of overall survival from the Japanese phase III J-ALEX study for Alecensa® were presented on June 2 at the 2019 American Society of Clinical Oncology Annual Meeting, taking place from May 31 to June 4 in Chicago, IL, United States.
June 3, 2019
·
3 min read
Business
Ethris Announces Expansion of Leadership Team
Thomas Langenickel, M.D. appointed to Chief Medical Officer as lead program ETH42 advances toward clinical trials
June 3, 2019
·
2 min read
Saluda Medical Announces Clinical Study Results for Evoke® ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
New Results Highlight the Importance of Objective Neurophysiological Measures and Clinically Meaningful Functional Outcomes
June 3, 2019
·
4 min read
Policy
Echinococcus multilocularis: A tiny but terrible tapeworm
Echinococcus multilocularis is an emerging parasite in Canada.
June 3, 2019
·
1 min read
Drug Development
Avacta Group plc TMAC Programme Accelerates: Clinical Trial Planned for Early 2020
Key linker element of Avacta’s novel TMAC™ drug conjugate to be tested in humans within 12 months
June 3, 2019
·
4 min read
Previous
19 of 30
Next